INTEGRATION+ is an implementation research focused on malaria in pregnancy, with the potential to change national health prevention policies to protect an additional 13 million pregnant women each year from malaria. A consortium of universities and research institutions from 6 African countries and 2 European countries applied to fund this project to European Commission (EDCTP) and USA (PMI).
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including
Pregnant women, babies and children under 5 years of age are the most vulnerable to malaria. In 2018, around 11 million pregnant women and 24 million children got malaria. Furthermore,
In this article published by Nature, Prof. Francine Ntoumi addresses how the efforts to tackle Covid-19 are consequently and tragically neglecting all other diseases, for which it is estimated that